Soluble CTLA-4 mainly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity to allow for inflammation resolution
This study shows that soluble CTLA-4 from Treg cells inhibits type 1 inflammation while preserving type 2 immunity, aiding inflammation resolution.
bioRxiv · May 26, 2023Immunology